|
|||||||||||||||||
|
EID
Home | Ahead of Print | Past
Issues | EID Search | Contact
Us | Announcements | Suggested
Citation | Submit Manuscript
Volume 11, Number 6, June 2005 Integrating Escherichia coli Antimicrobial Susceptibility Data from Multiple Surveillance ProgramsJohn M. Stelling,*† Karin Travers,* Ronald N. Jones,‡§ Philip J. Turner,¶
Thomas F. O'Brien,*† and Stuart B. Levy*§ |
||
|
Back to article | |
Figure 4. SENTRY results for supplemental antimicrobial drugs tested only by SENTRY. Annual nonsusceptibility rates of Escherichia coli, 1997–2001. AMC, amoxicillin/clavulanic acid; NAL, nalidixic acid; TET, tetracycline. |
|
|
|
EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z |
|
This page last reviewed May 20, 2005 |
|
Emerging
Infectious Diseases Journal |
|